Placental fractalkine immunoreactivity in preeclampsia and its correlation with histopathological changes in the placenta and adverse pregnancy outcomes^*

References

• Lowe SA, Bowyer L, Lust K, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55:e1–e29.
   PubMed Web of Science ®Google Scholar
• Lambert G, Brichant JF, Hartstein G, et al. Preeclampsia: an update. Acta Anaesthesiol Belg. 2014;65:137–149.
   PubMedGoogle Scholar
• Myatt L. Role of placenta in preeclampsia. Endocrine. 2002;19:103–111.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2:72–83.
   PubMed Web of Science ®Google Scholar
• Kim KW, Vallon-Eberhard A, Zigmond E, et al. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 2011;118:e156–e167.
   PubMed Web of Science ®Google Scholar
• D'Haese JG, Demir IE, Friess H, et al. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets. 2010;14:207–219.
   PubMed Web of Science ®Google Scholar
• Ruth JH, Volin MV, Haines GK, et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum. 2001;44:1568–1581.
   PubMed Web of Science ®Google Scholar
• Ruze A, Zhao Y, Li H, et al. Low shear stress upregulates the expression of fractalkine through the activation of mitogen-activated protein kinases in endothelial cells. Blood Coagul Fibrinolysis. 2018;29:361–368.
   PubMed Web of Science ®Google Scholar
• Sindhu S, Akhter N, Arefanian H, et al. Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes. J Diabetes Metab Disord. 2017;16:15.
   PubMed Web of Science ®Google Scholar
• Siwetz M, Dieber-Rotheneder M, Cervar-Zivkovic M, et al. Placental fractalkine is up-regulated in severe early-onset preeclampsia. Am J Pathol. 2015;185:1334–1343.
   PubMed Web of Science ®Google Scholar
• Zhou B, Xu H, Ni K, et al. Expression of chemokine XCL2 and CX3CL1 in lung cancer. Med Sci Monit. 2016;22:1560–1565.
   PubMed Web of Science ®Google Scholar
• Zou Y, Li Y, Lu L, et al. Correlation of fractalkine concentrations in serum and synovial fluid with the radiographic severity of knee osteoarthritis. Ann Clin Biochem. 2013;50:571–575.
   PubMed Web of Science ®Google Scholar
• Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91:521–530.
   PubMed Web of Science ®Google Scholar
• Wojdasiewicz P, Poniatowski LA, Kotela A, et al. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis. Arch Immunol Ther Exp. 2014;62:395–403.
   PubMed Web of Science ®Google Scholar
• Hannan NJ, Salamonsen LA. CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol Reprod. 2008;79:58–65.
   PubMed Web of Science ®Google Scholar
• Hannan NJ, Jones RL, Critchley HOD, et al. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling. J Clin Endocrinol Metab. 2004;89:6119–6129.
   PubMed Web of Science ®Google Scholar
• Szukiewicz D, Kochanowski J, Mittal TK, et al. Chorioamnionitis (ChA) modifies CX3CL1 (fractalkine) production by human amniotic epithelial cells (HAEC) under normoxic and hypoxic conditions. J Inflamm. 2014;11:12.
   Google Scholar
• Szukiewicz D, Kochanowski J, Pyzlak M, et al. Fractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placenta. Mediators Inflamm. 2013;2013:1.
   Web of Science ®Google Scholar
• Stepanian A, Benchenni S, Beillat-Lucas T, et al. Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study. Plos One. 2009;4:e6192.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. ACOG Practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet. 2002;33:67–75.
   Google Scholar
• Usta A, Turan G, Adali E. The expression of cyclophilin A in ovarian endometrioma: its correlation with recurrence and vascularity. Tohoku J Exp Med. 2017;243:141–150.
   PubMed Web of Science ®Google Scholar
• Inan S, Kuscu NK, Vatansever S, et al. Increased vascular surface density in ovarian endometriosis. Gynecol Endocrinol. 2003;17:143–150.
   PubMed Web of Science ®Google Scholar
• Siwetz M, Blaschitz A, Kremshofer J, et al. Metalloprotease dependent release of placenta derived fractalkine. Mediators Inflamm. 2014;2014:1.
   Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonat Med. 2006;11:309–316.
   PubMed Web of Science ®Google Scholar
• Austgulen R, Lien E, Liabakk NB, et al. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1994;57:149–155.
   PubMed Web of Science ®Google Scholar
• Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80–86.
   PubMed Web of Science ®Google Scholar
• Lau SY, Guild SJ, Barrett CJ, et al. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol. 2013;70:412–427.
   PubMed Web of Science ®Google Scholar
• Soma H, Yoshida K, Mukaida T, et al. Morphologic changes in the hypertensive placenta. Contrib Gynecol Obstet. 1982;9:58–75.
   PubMedGoogle Scholar
• Boyd PA, Scott A. Quantitative structural studies on human placentas associated with pre-eclampsia, essential hypertension and intrauterine growth retardation. Br J Obstet Gynaecol. 1985;92:714–721.
   PubMedGoogle Scholar
• Li Y, Zhao Y-J, Zou Q-Y, et al. Preeclampsia does not alter vascular growth and expression of CD31 and vascular endothelial cadherin in human placentas. J Histochem Cytochem. 2015;63:22–31.
   PubMed Web of Science ®Google Scholar
• Uras N, Oguz SS, Zergeroglu S, et al. CD31 and factor VIII in angiogenesis of normal and pre-eclamptic human placentas. J Obstet Gynaecol J Inst Obstet Gynaecol. 2012;32:533–536.
   Web of Science ®Google Scholar
• Chen LM, Liu B, Zhao HB, et al. TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta. 2010;31:75–80.
   PubMed Web of Science ®Google Scholar
• Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol. 1996;32:157–169.
   PubMed Web of Science ®Google Scholar
• Jiang DQ, Liu H, Zhang SB, et al. Aspirin inhibits tumor necrosis factor-alpha-stimulated fractalkine expression in human umbilical vein endothelial cells. Chin Med J (Engl). 2009;122:1147–1153.
   PubMed Web of Science ®Google Scholar
• Talari H, Mesdaghinia E, Abedzadeh Kalahroudi M. Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow. Iran Red Crescent Med J. 2014;16:e17175.
   PubMed Web of Science ®Google Scholar